Antimicrobial susceptibility and β-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections

Journal of Chemotherapy

Volumn 19, Issue 5, 2007, Pages 495-499

  Blandino, Giovanna ^a   Milazzo, I ^a   Fazio, D ^a   Puglisi, S ^a   Pisano, M ^a   Speciale, A ^a   Pappalardo, S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Aerobes; Anaerobes; Antimicrobial susceptibility; Orofacial infections

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CEFOXITIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; METRONIDAZOLE; PENICILLIN G;

ADULT; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CAMPYLOBACTER RECTUS; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH INFECTION; PUS;

EID: 36549050773     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.5.495     Document Type: Article

References (15)

1. Brook I, Frazier EH, Gher ME. Aerobic and anaerobic microbiology of periapical abscess. Oral Microbiol Immunol 1991; 6 (2): 123-125.
2. Baker KA, Fotos PG. The management of odontogenic infections. A rationale for appropriate chemotherapy. Dent Clin North Am 1994; 38 (4): 689-706.
3. Armitage GC. Classifying periodontal diseases - a long-standing dilemma. Periodontol 2000 2002; 30: 9-23.
4. Blandino G, Lo Bue AM, Milazzo I, Nicolosi DV, Cali G, Cannavo V, Rossetti B. Comparison of systemic flurithromycin therapy and clinical procedures in the treatment of periodontal diseases. J Chemother 2004; 16(2): 151-155.
5. Fosse T, Madinier I, Hitzig C, Charbit Y. Prevalence of beta-lactamase-producing strains among 149 anaerobic gram-negative rods isolated from periodontal pockets. Oral Microbiol Immunol 1999; 14 (6): 352-357.
6. Kuriyama T, Karasawa T, Nakagawa K, Yamamoto E, Nakamura S. Incidence of β-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections. Oral Microbiol Immunol 2001; 16: 10-15.
7. Milazzo I, Blandino G, Musumeci R, Nicoletti G, Lo Bue AM, Speciale A. Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. Int J Antimicrob Agents 2002; 20(6): 451-456.
8. Milazzo I, Blandino G, Caccamo F, Musumeci R, Nicoletti G, Speciale A. Faropenem, a new oral penem: antibacterial activity against selected anaerobic and fastidious periodontal isolates. J Antimicrob Chemother 2003; 51(3): 721-725.
9. Kuriyama T, Karasawa T, Nakagawa K, Yamamoto E, Nakamura S. Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections. Oral Microbiol Immunol. 2002 Apr; 17(2): 132-135.
10. th edn. Approved Standard. NCCLS Document M11-A6. Villanova: National Committee for Clinical Laboratory Standards, 2004.
11. Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing. Document M100-S15. Wayne PA: CLSI, 2005.
12. Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003 J Antimicrob Chemother 2006; 57: 992-998.
13. Sandor GK, Low DE, Judd PL, Davidson RJ. Antimicrobial treatment options in the management of odontogenic infections. J Can Dent Assoc 1998; 64(7): 508-514.
14. Lo Bue AM, Blandino G, Milazzo I, Pasquantonio G, Speciale A, Nicoletti G.Antibacterial activity and post-antibiotic effect of flurithromycin compared with other macrolides and penicillins against periodontal pathogens J Chemother. 2001; 13(3): 255-259
15. Oh H. and Edlund C. Mechanism of quinolone resistance in anerobic bacteria. Clin Microbiol Infect 2003; 9: 512-517.